CAPRICOR THERAPEUTICS, INC. - Common Stock (CAPR)

Historical Holders from Q2 2019 to Q3 2025

Symbol: CAPR on Nasdaq
Type / Class: Equity / Common Stock
Shares outstanding: 45,782,552
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 14,429,896
Holdings value: $103,917,460
% of all portfolios: 0%
Number of holders: 112
Number of buys: 57
Number of sells: -60
Average buys %: +0%
Average sells %: -0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of CAPRICOR THERAPEUTICS, INC. - Common Stock (CAPR)

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
BlackRock, Inc.	6.5%		$38,658,889		2,966,914		BlackRock, Inc.	31 Dec 2024
VANGUARD GROUP INC	4.82%	-4.4%	$15,910,444	-$709,168	2,206,719	-4.3%	The Vanguard Group	30 Sep 2025

Institutional Holders of CAPRICOR THERAPEUTICS, INC. - Common Stock (CAPR)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q3	14,429,896	$103,917,460	+$2,871,479	$19,249,589	$27,492,126	$7.21	112
2025 Q2	13,740,752	$136,510,446	-$45,087,125	$54,171,249	$47,446,426	$9.93	105
2025 Q1	18,332,527	$174,018,005	+$4,472,871	$9,729,756	$14,146,673	$9.49	120
2024 Q4	17,327,955	$239,127,553	+$123,239,591	$23,520,260	$22,960,076	$13.8	107
2024 Q3	8,369,327	$127,297,422	+$33,779,392	$21,111,480	$26,693,550	$15.21	75
2024 Q2	6,426,234	$30,652,576	+$6,579,081	$1,782,549	$956,385	$4.77	60
2024 Q1	4,817,759	$32,711,658	+$5,474,658	$331,352	$674,926	$6.79	55
2023 Q4	4,019,035	$19,652,993	-$3,283,556	$380,442	$890,958	$4.89	37
2023 Q3	5,536,583	$18,934,429	+$9,929,580	$278,730	$443,916	$3.42	34
2023 Q2	2,624,364	$12,543,954	+$927,959	$79,826	$232,786	$4.78	32
2023 Q1	2,433,746	$10,269,762	-$1,225,035	$258,264	$361,232	$4.22	30
2022 Q4	2,739,017	$10,569,409	-$271,547	$760,876	$808,512	$3.86	31
2022 Q3	2,792,373	$16,752,192	+$1,609,613	$1,398,000	$1,557,000	$6	28
2022 Q2	2,543,515	$8,872,518	-$139,327	$935,000	$696,000	$3.49	27
2022 Q1	2,589,186	$8,879,200	+$964,475	$902,000	$751,000	$3.43	26
2021 Q4	2,320,262	$6,798,547	-$740,098	$895,000	$226,000	$2.93	24
2021 Q3	2,490,642	$10,025,330	-$5,545,456	$1,821,000	$837,000	$4.02	25
2021 Q2	3,528,427	$18,097,220	-$4,296,483	$1,529,000	$436,000	$5.13	26
2021 Q1	4,384,650	$20,517,844	+$13,558,859	$1,216,000	$605,000	$4.68	28
2020 Q4	1,499,334	$5,140,899	+$692,978	$893,000	$380,000	$3.43	24
2020 Q3	1,264,478	$6,640,688	+$1,920,376	$1,657,000	$520,000	$5.25	25
2020 Q2	940,377	$4,324,870	+$2,983,542	$253,000	$206,000	$4.6	30
2020 Q1	498,312	$597,000	+$332,841			$1.2	15
2019 Q4	214,939	$275,000	+$78,218			$1.29	11
2019 Q3	123,654	$459,000	+$151,133			$3.73	15
2019 Q2	84,706	$281,000	+$281,000			$3.33	10